(Q40918159)

24 September 2017

title

CD154 variants associated with hyper-IgM syndrome can form oligomers and trigger CD40-mediated signals (English)

1 reference

24 September 2017

Garber E

1

1 reference

24 September 2017

Su L

2

1 reference

24 September 2017

Ehrenfels B

3

1 reference

24 September 2017

Karpusas M

4

1 reference

24 September 2017

Hsu YM

5

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

Journal of Biological Chemistry

24 September 2017

published in

1 reference

24 September 2017

volume

274

1 reference

24 September 2017

issue

47

1 reference

24 September 2017

page(s)

33545-33550

1 reference

Molecular approaches to analysis of X-linked immunodeficiencies

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

Deletions in the ligand for CD40 in X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

Hyper IgM syndrome associated with defective CD40-mediated B cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

The CD40 antigen and its ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

2 A crystal structure of an extracellular fragment of human CD40 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

Identification of residues on CD40 and its ligand which are critical for the receptor-ligand interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

Recombinant soluble trimeric CD40 ligand is biologically active

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

Human native soluble CD40L is a biologically active trimer, processed inside microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

Cleavage of membrane-bound CD40 ligand is not required for inducing B cell proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

CD40 ligand and its role in X-linked hyper-IgM syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

CD40 ligand mutants responsible for X-linked hyper-IgM syndrome associate with wild type CD40 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

The random inactivation of the X chromosome carrying the defective gene responsible for X-linked hyper IgM syndrome (X-HIM) in female carriers of HIGM1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

Classification of mutations in the human CD40 ligand, gp39, that are associated with X-linked hyper IgM syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

Molecular and biological characterization of a murine ligand for CD40

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

Cloning of TRAP, a ligand for CD40 on human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

Human CD40-ligand: molecular cloning, cellular distribution and regulation of expression by factors controlling IgE production

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

CD40 ligation induces lymphotoxin alpha gene expression in human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

CD40Lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

C to T mutation causing premature termination of CD40 ligand at amino acid 221 in a patient affected by Hyper IgM syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

CD40 ligand-transduced co-stimulation of T cells in the development of helper function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

Immunodeficiency with hyperimmunoglobulinemia M in two female patients is not associated with abnormalities of CD40 or CD40 ligand expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

Heteromultimeric complexes of CD40 ligand are present on the cell surface of human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

Analysis of gp39/CD40 interactions using molecular models and site-directed mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

Detailed comparison of two molecular models of the human CD40 ligand with an x-ray structure and critical assessment of model-based mutagenesis and residue mapping studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

Mutations of the CD40 ligand gene in 13 Japanese patients with X-linked hyper-IgM syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

Mutation analysis in CD40 ligand deficiency leading to X-linked hypogammaglobulinemia with hyper IgM syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

Evidence for a novel function of the CD40 ligand as a signalling molecule in T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.47.33545

21 January 2018

Identifiers

DOI

10.1074/JBC.274.47.33545

1 reference

24 September 2017

1 reference